A Canadian biopharmaceutical company focused on cannabinoid-based products has been awarded a Mitacs grant (sponsored by the Canadian government) to work on a treatment for lung inflammation associated with COVID-19, in tandem with the University of Toronto’s faculty of pharmacy. According to information procured exclusively, the publicly traded company in question, Avicanna Inc, will be […]
Read More
